Strategic Sourcing Leader - ARC at GE Healthcare

Wuxi, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Medical DevicesIndustries

Requirements

Interface effectively between Product Development and Global Operations / Supplier Management
Expertise in supplier strategy, selection, negotiation, and competitive quoting to achieve ICV/variance targets
Proficiency in SSR/PSSD standards (capability, Total Landed Cost, PRA, SPMC, Part-to-Print)
Ability to partner with Engineering and Category teams on DtV/should-cost analysis, design tradeoffs, and platform simplification
Knowledge of SQD/PQP, supplier technical reviews, process capability/PPAP, and launch quality/OTD requirements
Familiarity with NPI operating mechanics, program plans, material readiness, and factory fulfillment
Compliance with GEHC QMS/Purchasing Controls and Delegation of Authority (DOA) for contracts, LTBs, and variances
Skills in obsolescence/EOL mitigation, supply risk management, lifetime buys, and Installed Base continuity
Experience resolving supplier quality issues (SCARs, DPPM) and executing manufacturing transfers
Alignment with GE HealthCare behaviors: humility, trust-building, transparency, focus, ownership, and integrity

Responsibilities

Define and execute segment supplier strategy (strategic/dual-source/localization), run competitive quoting/negotiations, and secure ICV/variance targets at each gate
Lead Supplier Selection Review (SSR) tollgates (A/B) to secure leadership approval of nominations
Partner with Engineering and Category teams on DtV/should-cost analysis, design tradeoffs, platform simplification; maintain ICV allocation/tracking for new/carryover parts
Coordinate SQD/PQP inputs, lead supplier technical reviews, verify process capability/PPAP for launch quality/OTD
Drive material readiness and factory fulfillment with Production/Materials per NPI mechanics and program plan
Operate within GEHC QMS/Purchasing Controls, obtain DOA approvals for supplier contracts, LTBs, variances (M0–M9)
Own obsolescence/EOL and supply risk mitigation (M5–M9): alternate components, dual-sourcing, lifetime buys; ensure IB continuity, cost productivity, service parts readiness
Partner with IB/Product Engineering and SQD to resolve quality issues (SCARs, DPPM) and execute compliant manufacturing transfers

Skills

Supplier Strategy

Supplier Selection

Negotiation

Cost Analysis

DtV

Should-Cost

ICV

SSR

PSSD

PPAP

SQD

PQP

Obsolescence Management

Risk Mitigation

NPI

QMS

GE Healthcare

Healthcare technology and data analytics provider

About GE Healthcare

GE Healthcare provides a range of healthcare technologies and services aimed at improving patient care. Its main products include imaging systems, mobile diagnostic devices, patient monitoring solutions, and advanced software for data analysis. These products help medical professionals make informed decisions and enhance the efficiency of healthcare delivery. Unlike many competitors, GE Healthcare invests significantly in research and development, allocating $1 billion each year to innovate and enhance its offerings. The company’s goal is to support healthcare providers in delivering better patient outcomes, as evidenced by its technology supporting over 300,000 patients daily and managing 2 billion patient scans each year.

Chicago, IllinoisHeadquarters

1892Year Founded

N/ACompany Stage

Data & Analytics, HealthcareIndustries

10,001+Employees

Risks

Emerging AR technologies increase competition in medical imaging.

Regulatory challenges may delay AI application expansions in healthcare.

Dependence on clinical trial success for new product market positioning.

Differentiation

GE Healthcare invests $1 billion annually in R&D for product innovation.

The company supports over 300,000 patients daily with its healthcare technologies.

GE Healthcare's AIR Recon DL offers 3D motion-insensitive imaging for enhanced MRI quality.

Upsides

Acquisition of Caption Health expands AI-powered ultrasound capabilities.

Successful Phase III trial of [18F]flurpiridaz enhances coronary artery disease detection.

Collaboration with Wayra accelerates digital health innovation in EMEA.

Land your dream remote job 3x faster with AI

Try Jobo Free